Accéder au contenu
Merck
  • An in vivo antilymphatic screen in zebrafish identifies novel inhibitors of mammalian lymphangiogenesis and lymphatic-mediated metastasis.

An in vivo antilymphatic screen in zebrafish identifies novel inhibitors of mammalian lymphangiogenesis and lymphatic-mediated metastasis.

Molecular cancer therapeutics (2014-07-24)
Jonathan W Astin, Stephen M F Jamieson, Tiffany C Y Eng, Maria V Flores, June P Misa, Annie Chien, Kathryn E Crosier, Philip S Crosier
RÉSUMÉ

The growth of new lymphatic vessels (lymphangiogenesis) in tumors is an integral step in the metastatic spread of tumor cells, first to the sentinel lymph nodes that surround the tumor and then elsewhere in the body. Currently, no selective agents designed to prevent lymphatic vessel growth have been approved for clinical use, and there is an important potential clinical niche for antilymphangiogenic agents. Using a zebrafish phenotype-based chemical screen, we have identified drug compounds, previously approved for human use, that have antilymphatic activity. These include kaempferol, a natural product found in plants; leflunomide, an inhibitor of pyrimidine biosynthesis; and cinnarizine and flunarizine, members of the type IV class of calcium channel antagonists. Antilymphatic activity was confirmed in a murine in vivo lymphangiogenesis Matrigel plug assay, in which kaempferol, leflunomide, and flunarizine prevented lymphatic growth. We show that kaempferol is a novel inhibitor of VEGFR2/3 kinase activity and is able to reduce the density of tumor-associated lymphatic vessels as well as the incidence of lymph node metastases in a metastatic breast cancer xenograft model. However, in this model, kaempferol administration was also associated with tumor deposits in the pancreas and diaphragm, and flunarizine was found to be tumorigenic. Although this screen revealed that zebrafish is a viable platform for the identification and development of mammalian antilymphatic compounds, it also highlights the need for focused secondary screens to ensure appropriate efficacy of hits in a tumor context.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Ethyl alcohol, Pure, 200 proof, ACS reagent, ≥99.5%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
DAPI, for nucleic acid staining
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
L-Lysine monohydrochloride, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Rapamycine, Ready Made Solution, 2.5 mg/mL in DMSO (2.74 mM), from Streptomyces hygroscopicus
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
Ethanol solution, certified reference material, 2000 μg/mL in methanol
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Cinnarizine, powder
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Leflunomide, Immunosuppressant
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Flunarizine dihydrochloride, ≥98% (TLC)
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
L-Lysine monohydrochloride, reagent grade, ≥98% (HPLC)
Référence
Conditionnement
Disponibilité
Prix
Quantité
USP
Leflunomide, United States Pharmacopeia (USP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
L-Lysine monohydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Référence
Conditionnement
Disponibilité
Prix
Quantité
Lysine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
L-Lysine monohydrochloride, BioUltra, ≥99.5% (AT)
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
Rapamycin, VETRANAL®, analytical standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
Isoflurane, European Pharmacopoeia (EP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
Leflunomide, Pharmaceutical Secondary Standard; Certified Reference Material
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
L-Lysine hydrochloride solution, 100 mM amino acid in 0.1 M HCl, analytical standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
Flunarizine dihydrochloride, European Pharmacopoeia (EP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
L-Lysine monohydrochloride, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Référence
Conditionnement
Disponibilité
Prix
Quantité
Leflunomide, European Pharmacopoeia (EP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
Leflunomide for peak identification, European Pharmacopoeia (EP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
Cinnarizine, European Pharmacopoeia (EP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité